CME Group EBITDA 2010-2024 | CME
CME Group annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- CME Group EBITDA for the quarter ending September 30, 2024 was $1.108B, a 21.97% increase year-over-year.
- CME Group EBITDA for the twelve months ending September 30, 2024 was $4.187B, a 16.39% increase year-over-year.
- CME Group 2023 annual EBITDA was $3.788B, a 12.13% increase from 2022.
- CME Group 2022 annual EBITDA was $3.379B, a 11.48% increase from 2021.
- CME Group 2021 annual EBITDA was $3.031B, a 2.3% decline from 2020.
CME Group Annual EBITDA
(Millions of US $) |
| 2023 |
$3,788 |
| 2022 |
$3,379 |
| 2021 |
$3,031 |
| 2020 |
$3,102 |
| 2019 |
$3,061 |
| 2018 |
$2,856 |
| 2017 |
$2,519 |
| 2016 |
$2,426 |
| 2015 |
$2,217 |
| 2014 |
$2,002 |
| 2013 |
$1,875 |
| 2012 |
$1,945 |
| 2011 |
$2,282 |
| 2010 |
$2,115 |
| 2009 |
$1,853 |
CME Group Quarterly EBITDA
(Millions of US $) |
| 2024-09-30 |
$1,108 |
| 2024-06-30 |
$1,085 |
| 2024-03-31 |
$1,045 |
| 2023-12-31 |
$950 |
| 2023-09-30 |
$909 |
| 2023-06-30 |
$928 |
| 2023-03-31 |
$1,002 |
| 2022-12-31 |
$759 |
| 2022-09-30 |
$829 |
| 2022-06-30 |
$840 |
| 2022-03-31 |
$951 |
| 2021-12-31 |
$726 |
| 2021-09-30 |
$710 |
| 2021-06-30 |
$771 |
| 2021-03-31 |
$823 |
| 2020-12-31 |
$636 |
| 2020-09-30 |
$643 |
| 2020-06-30 |
$751 |
| 2020-03-31 |
$1,073 |
| 2019-12-31 |
$689 |
| 2019-09-30 |
$806 |
| 2019-06-30 |
$821 |
| 2019-03-31 |
$745 |
| 2018-12-31 |
$742 |
| 2018-09-30 |
$604 |
| 2018-06-30 |
$718 |
| 2018-03-31 |
$793 |
| 2017-12-31 |
$589 |
| 2017-09-30 |
$618 |
| 2017-06-30 |
$658 |
| 2017-03-31 |
$654 |
| 2016-12-31 |
$596 |
| 2016-09-30 |
$581 |
| 2016-06-30 |
$618 |
| 2016-03-31 |
$632 |
| 2015-12-31 |
$526 |
| 2015-09-30 |
$574 |
| 2015-06-30 |
$553 |
| 2015-03-31 |
$564 |
| 2014-12-31 |
$528 |
| 2014-09-30 |
$488 |
| 2014-06-30 |
$472 |
| 2014-03-31 |
$514 |
| 2013-12-31 |
$383 |
| 2013-09-30 |
$461 |
| 2013-06-30 |
$567 |
| 2013-03-31 |
$464 |
| 2012-12-31 |
$435 |
| 2012-09-30 |
$457 |
| 2012-06-30 |
$534 |
| 2012-03-31 |
$519 |
| 2011-12-31 |
$453 |
| 2011-09-30 |
$638 |
| 2011-06-30 |
$600 |
| 2011-03-31 |
$590 |
| 2010-12-31 |
$544 |
| 2010-09-30 |
$510 |
| 2010-06-30 |
$582 |
| 2010-03-31 |
$479 |
| 2009-12-31 |
$467 |
| 2009-09-30 |
$466 |
| 2009-06-30 |
$461 |
| 2009-03-31 |
$460 |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Securities Exchanges |
$86.202B |
$5.579B |
|
CME Group is the largest futures exchange in the world in terms of trading volume as well as notional value traded. CME Group offers a broad range of products covering major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. Trades are executed through CME Group's electronic trading platforms, open outcry and privately negotiated transactions. CME Group also operates one of the world's leading central counterparty clearing providers through CME Clearing and CME Clearing Europe, which offer clearing and settlement services across asset classes for exchange-traded and over-the-counter derivatives. Apart from CME and CBOT, the company operates New York Mercantile Exchange, Inc. (NYMEX) and Commodity Exchange, Inc. (COMEX), CME Clearing Europe Limited (CMECE) and CME Europe Limited (CME Europe). The company reports the results of its operations as one operating segment mainly comprised of CME, CBOT, NYMEX and COMEX.
|
